# Observational Registry of Acthar Gel for Participants With Multiple Sclerosis Relapse

> **NCT02633033** · — · COMPLETED · sponsor: **Mallinckrodt** · enrollment: 160 (actual)

## Conditions studied

- Multiple Sclerosis, Relapsing-Remitting

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02633033
- **Lead sponsor:** Mallinckrodt
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-24
- **Primary completion:** 2019-05-09
- **Final completion:** 2019-05-09
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2019-12-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02633033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02633033, "Observational Registry of Acthar Gel for Participants With Multiple Sclerosis Relapse". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02633033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*